Paul Gregor
Chief Executive Officer at Rimonyx Pharmaceuticals Ltd.
Paul Gregor active positions
| Companies | Position | Start | End |
|---|---|---|---|
Rimonyx Pharmaceuticals Ltd.
 Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Chief Executive Officer | 2001-12-31 | - |
| Founder | 2009-11-24 | - |
Career history of Paul Gregor
Former positions of Paul Gregor
| Companies | Position | Start | End |
|---|---|---|---|
| W WORL | Chief Tech/Sci/R&D Officer | - | - |
| Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | - | - |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
| The Salk Institute for Biological Studies | Corporate Officer/Principal | - | - |
| National Institute on Drug Abuse | Corporate Officer/Principal | - | - |
Training of Paul Gregor
| Weizmann Institute of Science | Undergraduate Degree |
Statistics
International
| United States | 6 |
| Israel | 3 |
Operational
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 1 |
| Founder | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Government | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| W WORL | Health Technology |
| Private companies | 4 |
|---|---|
Rimonyx Pharmaceuticals Ltd.
Rimonyx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rimonyx Pharmaceuticals Ltd. develops drugs targeted at glycosaminoglycan and protein interactions. It identified a series of novel anti-inflammatory compounds and has recently partnered its lead drug candidate, RX-111, for further preclinical and clinical development. It is focused on developing additional products for a variety of inflammatory and autoimmune indications. The company was founded in 2001 and is headquartered in Ness-Ziona, Israel | Health Technology |
| National Institute on Drug Abuse | Government |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
| Bayer Pharmaceuticals Corp. |
- Stock Market
- Insiders
- Paul Gregor
- Experience
